Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer
暂无分享,去创建一个
K. Naoki | M. Katagiri | S. Igawa | J. Sasaki | H. Manabe | T. Fukui | Masashi Kasajima | M. Yokoba | H. Mitsufuji | M. Kubota | T. Ono